<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>128(2)</volume><submitter>de Ruigh AA</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To assess the effect of transabdominal amnioinfusion or no intervention on long-term outcomes in children born after second-trimester prelabour rupture of the membranes (PROM between 16&lt;sup>+0/7&lt;/sup> -24&lt;sup>+0/7&lt;/sup>  weeks) and oligohydramnios.&lt;h4>Population&lt;/h4>Follow up of infants of women who participated in the randomised controlled trial: PPROMEXIL-III (NTR3492).&lt;h4>Methods&lt;/h4>Surviving infants were invited for neurodevelopmental assessment up to 5 years of corrected age using a Bayley Scales of Infant and Toddler Development or a Wechsler Preschool and Primary Scale of Intelligence. Parents were asked to complete several questionnaires.&lt;h4>Main outcome measures&lt;/h4>Neurodevelopmental outcomes were measured. Mild delay was defined as -1 standard deviation (SD), </pubmed_abstract><journal>BJOG : an international journal of obstetrics and gynaecology</journal><pagination>292-301</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7818451</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Child outcomes after amnioinfusion compared with no intervention in women with second-trimester rupture of membranes: a long-term follow-up study of the PROMEXIL-III trial.</pubmed_title><pmcid>PMC7818451</pmcid><pubmed_authors>Woiski M</pubmed_authors><pubmed_authors>van Teeffelen AS</pubmed_authors><pubmed_authors>van Kempen L</pubmed_authors><pubmed_authors>Simons NE</pubmed_authors><pubmed_authors>de Ruigh AA</pubmed_authors><pubmed_authors>Oepkes D</pubmed_authors><pubmed_authors>van Wassenaer-Leemhuis AG</pubmed_authors><pubmed_authors>Pajkrt E</pubmed_authors><pubmed_authors>Aarnoudse-Moens C</pubmed_authors><pubmed_authors>van 't Hooft J</pubmed_authors><pubmed_authors>van de Beek C</pubmed_authors><pubmed_authors>Roseboom TJ</pubmed_authors><pubmed_authors>Derks JB</pubmed_authors><pubmed_authors>Mol BW</pubmed_authors><pubmed_authors>Porath MM</pubmed_authors><pubmed_authors>Haak MC</pubmed_authors><pubmed_authors>Duijnhoven RG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Child outcomes after amnioinfusion compared with no intervention in women with second-trimester rupture of membranes: a long-term follow-up study of the PROMEXIL-III trial.</name><description>&lt;h4>Objective&lt;/h4>To assess the effect of transabdominal amnioinfusion or no intervention on long-term outcomes in children born after second-trimester prelabour rupture of the membranes (PROM between 16&lt;sup>+0/7&lt;/sup> -24&lt;sup>+0/7&lt;/sup>  weeks) and oligohydramnios.&lt;h4>Population&lt;/h4>Follow up of infants of women who participated in the randomised controlled trial: PPROMEXIL-III (NTR3492).&lt;h4>Methods&lt;/h4>Surviving infants were invited for neurodevelopmental assessment up to 5 years of corrected age using a Bayley Scales of Infant and Toddler Development or a Wechsler Preschool and Primary Scale of Intelligence. Parents were asked to complete several questionnaires.&lt;h4>Main outcome measures&lt;/h4>Neurodevelopmental outcomes were measured. Mild delay was defined as -1 standard deviation (SD), </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2025-05-31T23:03:08.876Z</modification><creation>2025-05-31T23:03:08.876Z</creation></dates><accession>S-EPMC7818451</accession><cross_references><pubmed>31984652</pubmed><doi>10.1111/1471-0528.16115</doi></cross_references></HashMap>